Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
227 | 44923 | 46.9 | 91% |
Classes in level above (level 4) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
0 | 3633673 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//MED |
Classes in level below (level 2) |
ID, lev. below |
Publications | Label for level below |
---|---|---|
760 | 11727 | ETS 1//PU1//HEMANGIOBLAST |
1412 | 7537 | COFFIN LOWRY SYNDROME//ERK5//JNK |
1805 | 5741 | EGR 1//C FOS//CREM |
2205 | 4410 | ID 1//NRSF//MYC |
2335 | 4006 | I KAPPA B//C REL//IKK |
2437 | 3630 | SERUM RESPONSE FACTOR//MYOCARDIN//KLF4 |
3120 | 1786 | BRANCHIO OCULO FACIAL SYNDROME//RIZ1//BCL6 |
3160 | 1655 | NUR77//NURR1//TR4 |
3308 | 1338 | ASTROCYTE ELEVATED GENE 1//AEG 1//DREF |
3353 | 1244 | 14 3 3 PROTEINS//14 3 3 SIGMA//14 3 3 |
3430 | 1129 | PROTEIN KINASE D//PROTEIN KINASE D PKD//MEF2C |
3737 | 720 | PIM 2//TRANSLATIONALLY CONTROLLED TUMOR PROTEIN//TCTP |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | TRANSCRIPTION FACTOR | Author keyword | 168 | 15% | 2% | 1012 |
2 | ETS 1 | Author keyword | 129 | 56% | 0% | 156 |
3 | C JUN | Author keyword | 124 | 27% | 1% | 387 |
4 | NUR77 | Author keyword | 120 | 67% | 0% | 107 |
5 | ID 1 | Author keyword | 113 | 63% | 0% | 113 |
6 | ASTROCYTE ELEVATED GENE 1 | Author keyword | 110 | 95% | 0% | 37 |
7 | PU1 | Author keyword | 105 | 55% | 0% | 132 |
8 | SERUM RESPONSE FACTOR | Author keyword | 97 | 57% | 0% | 115 |
9 | MYC | Author keyword | 88 | 27% | 1% | 276 |
10 | AEG 1 | Author keyword | 85 | 86% | 0% | 43 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TRANSCRIPTION FACTOR | 168 | 15% | 2% | 1012 | Search TRANSCRIPTION+FACTOR | Search TRANSCRIPTION+FACTOR |
2 | ETS 1 | 129 | 56% | 0% | 156 | Search ETS+1 | Search ETS+1 |
3 | C JUN | 124 | 27% | 1% | 387 | Search C+JUN | Search C+JUN |
4 | NUR77 | 120 | 67% | 0% | 107 | Search NUR77 | Search NUR77 |
5 | ID 1 | 113 | 63% | 0% | 113 | Search ID+1 | Search ID+1 |
6 | ASTROCYTE ELEVATED GENE 1 | 110 | 95% | 0% | 37 | Search ASTROCYTE+ELEVATED+GENE+1 | Search ASTROCYTE+ELEVATED+GENE+1 |
7 | PU1 | 105 | 55% | 0% | 132 | Search PU1 | Search PU1 |
8 | SERUM RESPONSE FACTOR | 97 | 57% | 0% | 115 | Search SERUM+RESPONSE+FACTOR | Search SERUM+RESPONSE+FACTOR |
9 | MYC | 88 | 27% | 1% | 276 | Search MYC | Search MYC |
10 | AEG 1 | 85 | 86% | 0% | 43 | Search AEG+1 | Search AEG+1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DNA BINDING | 423 | 14% | 6% | 2794 |
2 | DEFINITIVE HEMATOPOIESIS | 354 | 61% | 1% | 376 |
3 | DOMINANT CONTROL REGION | 351 | 74% | 1% | 263 |
4 | NGFI B | 323 | 66% | 1% | 297 |
5 | TRANSCRIPTION FACTOR GATA 1 | 305 | 52% | 1% | 421 |
6 | C JUN | 303 | 22% | 3% | 1232 |
7 | MAP KINASE | 278 | 16% | 4% | 1631 |
8 | 14 3 3 PROTEINS | 274 | 47% | 1% | 427 |
9 | SERUM RESPONSE FACTOR | 264 | 36% | 1% | 592 |
10 | KRUPPEL LIKE FACTOR | 247 | 60% | 1% | 266 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CELL STEM CELL | 17 | 14% | 0% | 115 |
2 | CELL GROWTH & DIFFERENTIATION | 16 | 10% | 0% | 145 |
3 | ONCOGENE RESEARCH | 3 | 13% | 0% | 22 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The bone marrow niche for haematopoietic stem cells | 2014 | 121 | 109 | 76% |
Shared principles in NF-kappa B signaling | 2008 | 1561 | 165 | 58% |
NF-kappa B and rel proteins: Evolutionarily conserved mediators of immune responses | 1998 | 3488 | 166 | 70% |
Signaling to NF-kappa B | 2004 | 2169 | 347 | 56% |
NF-kappa B, the first quarter-century: remarkable progress and outstanding questions | 2012 | 296 | 364 | 57% |
MYC on the Path to Cancer | 2012 | 344 | 214 | 49% |
Signal integration by JNK and p38 MAPK pathways in cancer development | 2009 | 635 | 159 | 64% |
NF-kappa B and the link between inflammation and cancer | 2012 | 265 | 179 | 60% |
NF-kappa B regulation in the immune system | 2002 | 1979 | 87 | 70% |
Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases | 2011 | 346 | 427 | 63% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CANC UK ST S PONSE | 34 | 93% | 0.0% | 13 |
2 | GENE REGULAT SIGNAL TRANSDUCT | 32 | 24% | 0.3% | 119 |
3 | ERASMUS STEM CELL | 21 | 69% | 0.0% | 18 |
4 | MOL BIOL CANC GENET | 20 | 100% | 0.0% | 9 |
5 | EXPT HEMATOPOIESIS UNIT | 18 | 83% | 0.0% | 10 |
6 | HEMATOPOIET STEM CELL | 17 | 36% | 0.1% | 37 |
7 | SIGNALING SYST | 16 | 44% | 0.1% | 28 |
8 | GEORGE WHIPPLE CANC | 16 | 25% | 0.1% | 54 |
9 | MED STRAHLENKUNDE ZELLFOR | 15 | 31% | 0.1% | 41 |
10 | IMMUNOBIOL CANC PROGRAM | 15 | 27% | 0.1% | 48 |
Related classes at same level (level 3) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000003534 | HER 2//TRASTUZUMAB//CHRONIC MYELOID LEUKEMIA |
2 | 0.0000003506 | MERKEL CELL CARCINOMA//P53//JC VIRUS |
3 | 0.0000003456 | DEVELOPMENTAL BIOLOGY//DEVELOPMENT//DROSOPHILA |
4 | 0.0000003116 | EXPERIMENTAL HEMATOLOGY//THROMBOPOIETIN//JOURNAL OF INTERFERON RESEARCH |
5 | 0.0000003109 | GENOME EDITING//CAS9//CRISPR |
6 | 0.0000003033 | AUTOPHAGY//TRAIL//APOPTOSIS |
7 | 0.0000002940 | CHROMATIN//CHROMOSOMA//NUCLEAR ENVELOPE |
8 | 0.0000002734 | POMPE DISEASE//PROTEIN KINASE CK2//GLYCOGEN STORAGE DISEASE TYPE II |
9 | 0.0000002537 | ACUTE PROMYELOCYTIC LEUKEMIA//ARSENIC TRIOXIDE//VITAMIN A |
10 | 0.0000002521 | CELL & TISSUE ENGINEERING//MESENCHYMAL STEM CELLS//ENDOTHELIAL PROGENITOR CELLS |